Crewe Advisors LLC West Pharmaceutical Services Inc Transaction History

Crewe Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$314.68 - $395.94 $22,342 - $28,111	71 Added 322.73%	93 $30,000
Q1 2024 May 13, 2024	BUY	$338.27 - $413.0 $7,441 - $9,086	22 New	22 $8,000
Q2 2023 Jul 28, 2023	SELL	$334.63 - $382.47 $20,077 - $22,948	-60 Reduced 92.31%	5 $1,000
Q4 2022 Feb 07, 2023	BUY	$209.34 - $261.61 $11,304 - $14,126	54 Added 490.91%	65 $15,000
Q3 2022 Nov 14, 2022	BUY	$246.08 - $343.65 $2,706 - $3,780	11 New	11 $3,000

803

64.4M

294K

490K

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $24.7B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

Get notified when there are updates to the investment portfolio of Crewe Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Crewe Advisors LLC with notifications on news.